ClinChoice

ClinChoice is a Contract Research Organization (CRO) that focuses on providing comprehensive services for the clinical development of innovative pharmaceuticals and medical devices both in China and internationally. Established in 2007 in the Tianjin Economic-Development Area, ClinChoice has actively expanded into key therapeutic areas and markets through organic growth and acquisitions. Currently, the company has over 4,000 employees across nearly 30 countries in Asia, Europe, and North America, offering flexible, efficient, high-quality, and one-stop services to innovative pharmaceutical and medical device clients worldwide. The ClinChoice brand has been repeatedly recognized both domestically and internationally with awards such as "Best Clinical CRO," "Best Company in Medical Services," and inclusion in the "Top 100 Brands in China's Life Science Service Enterprises," consistently leading the industry. ClinChoice is committed to serving pharmaceutical, medical device, and healthcare companies with innovative R&D capabilities in China and globally. Its business spans small molecule drugs, biologics, vaccines, cell/gene therapies, medical devices, traditional Chinese medicine, natural products, and health consumer goods. ClinChoice has successfully conducted full-service clinical trials for nearly 100 large multinational pharmaceutical enterprises and over 300 innovative startups (Biotech) at home and abroad, completing more than 1,500 clinical trials. It has participated in the design, development, implementation, and registration of clinical trials for 85 innovative drugs and over 20 biosimilars both domestically and internationally. The ClinChoice brand is also highly favored by investors. As of July 2022, it had completed multiple rounds of financing, including investments from well-known international institutions such as Lilly Asia Ventures, Goldman Sachs, Legend Capital, Taikang Asset Management, and Draper Fisher Jurvetson. In the future, ClinChoice will leverage its global team of experts in full-service clinical research to collaborate with all parties in advancing the clinical development of innovative pharmaceuticals and medical devices, jointly fostering a more sustainable industry ecosystem.